188 related articles for article (PubMed ID: 1690826)
41. Mucinous adenocarcinoma of prostate: a case report and review of the literature.
Nagakura K; Hayakawa M; Mukai K; Aikawa A; Nakamura H
J Urol; 1986 May; 135(5):1025-8. PubMed ID: 3007780
[TBL] [Abstract][Full Text] [Related]
42. Urethral metastasis from prostatic carcinoma as diagnosed by immunoperoxidase technique using prostate-specific antigen and prostate-specific acid phosphatase.
Koh E; Sekii K; Namiki M; Fujioka H; Onoue K; Sakurai M; Sonoda T
Eur Urol; 1987; 13(1-2):142-4. PubMed ID: 2438138
[TBL] [Abstract][Full Text] [Related]
43. [A case report: mucinous carcinoma of prostate].
Noma M; Mori N; Kobayashi Y; Hara T; Yamaguchi S
Hinyokika Kiyo; 2003 Oct; 49(10):591-3. PubMed ID: 14655602
[TBL] [Abstract][Full Text] [Related]
44. [Mucinous adenocarcinoma of the prostate: a case report and review of 32 cases on immunohistochemical study of both PSA and CEA].
Furuta A; Naruoka T; Hasegawa N; Suzuki Y; Ikemoto I; Oishi Y
Nihon Hinyokika Gakkai Zasshi; 2003 Jul; 94(5):570-3. PubMed ID: 12910933
[TBL] [Abstract][Full Text] [Related]
45. Mucinous urothelial-type adenocarcinoma of the prostate.
Ortiz-Rey JA; Dos Santos JE; Rodríguez-Castilla M; Alvarez C; Fariña L
Scand J Urol Nephrol; 2004; 38(3):256-7. PubMed ID: 15204383
[TBL] [Abstract][Full Text] [Related]
46. [Mucinous adenocarcinoma of the prostate with good response to hormonal therapy: a case report].
Ishizu K; Yoshihiro S; Joko K; Takihara H; Sakatoku J; Tanaka K
Hinyokika Kiyo; 1991 Sep; 37(9):1057-60. PubMed ID: 1664650
[TBL] [Abstract][Full Text] [Related]
47. Prostate-specific antigen in adenocarcinoma of the prostate.
N Engl J Med; 1988 Apr; 318(15):992-3. PubMed ID: 2451131
[No Abstract] [Full Text] [Related]
48. Mucin-producing urothelial-type adenocarcinoma of the prostate as a mimicker of colonic adenocarcinoma: a case report and review of the literature.
Chen YL; Chian JH; Hsiao PJ
Int J Surg Pathol; 2012 Apr; 20(2):191-5. PubMed ID: 21791488
[TBL] [Abstract][Full Text] [Related]
49. Papillary cystoadenocarcinoma of the prostate.
Takeuchi S; Higashi Y; Kobayashi I; Takahama M
Hinyokika Kiyo; 1992 Mar; 38(3):347-9. PubMed ID: 1381865
[TBL] [Abstract][Full Text] [Related]
50. [Immunohistochemical identification of specific prostatic phosphatases and specific prostatic antigen in prostatic tumors].
Bonetti F; Pisa R; Chilosi M; Loddo G; Menestrina F; Zamboni G; Pea M
Pathologica; 1983; 75(1040):789-95. PubMed ID: 6201809
[No Abstract] [Full Text] [Related]
51. Prostatic acid phosphatase, beta-glucuronidase and prostate specific antigen assays in fine needle aspirates from benign and malignant prostates.
Erickson DR; Hlavinka TC; Rockwood AP; Metter JD; Novicki DE; Fried MG
J Urol; 1991 Nov; 146(5):1402-7. PubMed ID: 1719247
[TBL] [Abstract][Full Text] [Related]
52. Mucinous adenocarcinoma of the prostate with endobronchial metastasis.
Lee DW; Ro JY; Sahin AA; Lee JS; Ayala AG
Am J Clin Pathol; 1990 Nov; 94(5):641-5. PubMed ID: 1700598
[TBL] [Abstract][Full Text] [Related]
53. Signet ring cell carcinoma of prostate. Immunohistochemical and ultrastructural study of a case.
Hejka AG; England DM
Urology; 1989 Sep; 34(3):155-8. PubMed ID: 2476883
[TBL] [Abstract][Full Text] [Related]
54. Primary prostatic signet-ring cell carcinoma.
Skodras G; Wang J; Kragel PJ
Urology; 1993 Sep; 42(3):338-42. PubMed ID: 7691016
[TBL] [Abstract][Full Text] [Related]
55. [Purification and enzyme immunoassay of tumor markers for prostate cancer: prostatic acid phosphatase, prostate-specific antigen and creatine kinase BB].
Morishita N; Minami Y; Ogawa S; Saito Y
Nihon Hinyokika Gakkai Zasshi; 1984 Mar; 75(3):404-13. PubMed ID: 6206268
[No Abstract] [Full Text] [Related]
56. Uses and limitations of prostate-specific antigen in the laboratory diagnosis of prostate cancer.
Wells DJ; Bennett BD; Gardner WA
South Med J; 1988 Feb; 81(2):218-20. PubMed ID: 2448884
[TBL] [Abstract][Full Text] [Related]
57. Correlation of prostate-specific acid phosphatase and prostate-specific antigen immunocytochemistry with survival in prostate carcinoma.
Hammond ME; Sause WT; Martz KL; Pilepich MV; Asbell SO; Rubin P; Myers RP; Farrow GM
Cancer; 1989 Feb; 63(3):461-6. PubMed ID: 2463874
[TBL] [Abstract][Full Text] [Related]
58. [Prostate antigen as a tumor marker of prostate cancer: (2). Changes of prostate antigen values during anti-cancer chemotherapy].
Kuriyama M; Takeuchi T; Shinoda I; Okano M; Fujimoto Y; Fujihiro S; Nishiura T; Murphy GP; Chu TM
Nihon Gan Chiryo Gakkai Shi; 1984 Dec; 19(10):2230-8. PubMed ID: 6085338
[No Abstract] [Full Text] [Related]
59. [Immunohistochemical study of prostatic acid phosphatase and prostatic specific antigen in prostatic carcinoma--a comparison of monoclonal antibody to polyclonal antibody].
Moriyama N; Taniguchi J; Hara M; Fukutani K; Matsushima H; Murakami T; Isurugi K; Kawabe K; Niijima T
Nihon Hinyokika Gakkai Zasshi; 1987 Nov; 78(11):1992-7. PubMed ID: 2453695
[No Abstract] [Full Text] [Related]
60. Mucinous adenocarcinoma of the prostate: histochemical and immunohistochemical studies.
Ro JY; Grignon DJ; Ayala AG; Fernandez PL; Ordonez NG; Wishnow KI
Hum Pathol; 1990 Jun; 21(6):593-600. PubMed ID: 1693591
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
